On January 1, 2018, amendments to Professional Practice Policy – 66, including changing its name from “Methadone Maintenance Treatment” to “Opioid Agonist Treatment,” came into effect. These amendments also include the introduction of new policy guides for buprenorphine/naloxone, and slow-release oral morphine.
On December 20, 2017, BC’s Minister of Mental Health and Addictions, Judy Darcy announced that take-home naloxone kits are now available at community pharmacies throughout British Columbia.
Required maintenance work to the College’s IT systems supporting eServices will take place between 5:00 pm Saturday, December 16 and 12:00pm Sunday, December 17.
Each year, the UBC Faculty of Pharmaceutical Science recognizes one of its remarkable alumni for creating a local, provincial, national or global impact in the field of community, research, hospital, governance, education or clinical pharmacy.
The College of Pharmacists of British Columbia would like to congratulate our Registrar, Bob Nakagawa, for being this year’s recipient.
On November 7, 2017, Health Canada implemented changes regarding the prescribing and dispensing of Mifegymiso.
The highlights from the November Board Meeting are now available.
As of October 23, 2017, The Ministry of Health will assume responsibility for issuing all PharmaNet FanOuts.
The College is pleased to announce the results of the most recent Board elections held for pharmacists in Districts 1, 3, 5, and 7.
The highlights from the September Board Meeting are now available.
Polls are now open for Metropolitan Vancouver (District 1), Vancouver Island/Coastal (District 3), and Community Hospitals(District 7). Completed electronic ballots must be submitted by 5:00pm on Friday, October 6, 2017.